Chamber and committees

Consistent information on the age of patients attending A&E is only available from 2010. The number of attendances recorded at main hospital A&E sites for patients aged under 16 is provided in the following table.

Health spend in Scotland is 7.5% higher per head than in England. This equates to over £880 million more spending comparatively on health services in Scotland, compared to England. Comparative spending between Scotland and England is set out as part of HM Treasury’s country and regional analysis. Figures are available from 2008-09 onward from the following location: https://www.gov.uk/government/collections/country-and-regional-analysis .

Pharmacists are core members of the healthcare workforce, and reforms introduced in the National Health and Social Care Workforce Plan will ensure that all GP practices have access to enhanced pharmacist and pharmacy technician support by 2021.

In 2017-18 funding for general practice pharmacy support was increased by a further £4.2 million. Based on this additional funding, over and above the original three year figure of £16.2 million, NHS Boards plan that by March 2018 they will have appointed over 200 whole time equivalent pharmacists and over 50 whole time equivalent pharmacy technicians working with or within GP practices. The final numbers of pharmacists required will depend on local planning arrangements to meet population needs, emerging new models of care, skill mix and developing multidisciplinary team working.

The Plan also sets out how we intend to recruit, develop and retain the multidisciplinary and flexible workforce we need to continue to deliver high quality healthcare for the people of Scotland. This will ensure we have the right people in the right place at the right time to continue to deliver high quality care that meets the needs of Scotland’s population.

The Scottish Government's letter DL (2017) 13 issued to all NHS Boards on 12 June 2017 provides an indication of the number of continuous glucose monitoring (CGM) devices and insulin pumps for adults that the 2017-18 financial year £2m additional funding would provide.

The Scottish Diabetes Survey (SDS) continues to publish data on insulin pumps provision for each calendar year. The intention is to include CGMs in the future. As this is new data, robustness and completeness will be considered in the context of the 2017 SDS publication.

Additional funding for the provision of continuous glucose monitoring devices for all ages and insulin pumps for adults for financial year 2017-18 is set out in the Scottish Government's letter (DL (2017) 13) issued to all NHS Boards on 12 June 2017.

This information requested is not held centrally.

The information requested is not available centrally.

Advice has been sought from a range of clinical specialists in the field, and the Scottish Government’s Senior Medical Officer, to obtain a comprehensive view on the effectiveness of Neuro-Electro Therapy (NET). Their responses indicate that NET is not used by the NHS in Scotland due to the lack of an accepted evidence base.

The most up-to-date review of the evidence conducted in Scotland that we are aware of was done in 2012 by the University of Aberdeen. Researchers there looked at the evidence base in support of the use of NET in opiate detoxification as a component of drugs rehabilitation. The study concluded that there was insufficient evidence regarding the effectiveness of NET at improving drug-free behaviour.

The number of children that have been diagnosed with Fetal Alcohol Syndrome in each year from 1999 - 2002 is not held centrally.

The Scottish Birth Record (SBR) was introduced in 2002. The number of babies reported in the SBR as having a diagnosis of ‘Fetal Alcohol Syndrome’ in Scotland during the period 2003 to 2017 is provided in the following table.

In 2010 the Scottish Government published a Scottish Good Practice Statement (SGPS) for GPs to ensure better and more consistent standards of care for ME/CFS. This was produced in wide consultation with NHS Scotland and is formally endorsed by the Royal College of General Practitioners (Scotland) and the Scottish Neuroscience Council, providing clear guidance for GPs about how ME/CFS care should be progressed.

In September 2017 the National Institute for Health and Care Excellence (NICE) decided that they will update their guidelines on ME in order to reflect new evidence. We will follow the progress of this work closely, but any decision on reviewing the SGPS would need to be taken after the updated guidelines from NICE are published as they will be reviewing the most up to date clinical evidence available.